Search
forResearch 10 of 294
- Randomized, double‐blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair
- A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women
- Topical Eflornithine
- Vaniqa--eflornithine 13.9% cream.
- Topical eflornithine hydrochloride improves the effectiveness of standard laser hair removal for treating pseudofolliculitis barbae: A randomized, double-blinded, placebo-controlled trial
- A method to improve the efficacy of topical eflornithine hydrochloride cream
- Adjuvant eflornithine to maintain IPL‐induced hair reduction in women with facial hirsutism: a randomized controlled trial
- Human Dermal Safety Studies with Eflornithine HCl 13.9% Cream (Vaniqa™), a Novel Treatment for Excessive Facial Hair
- Repurposing With Purpose: Treatment of Bachmann–Bupp Syndrome With Eflornithine and Implications for Other Polyaminopathies
- Synergy of Eflornithine Cream with Laser and Light-Based Systems for Hair Management
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →